Lipid lowering drugs should be considered too

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7025.252b (Published 27 January 1996) Cite this as: BMJ 1996;312:252
  1. A Taylor,
  2. J P Reckless
  1. Consultant clinical biochemist Consultant physician Royal United Hospital, Bath BA1 3NG

    EDITOR,—Janet Smith and Kevin S Channer describe the lack of translation into clinical practice of evidence from trials of secondary prevention of myocardial …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription